|
1
|
Ferro A, Peleteiro B, Malvezzi M, Bosetti
C, Bertuccio P, Levi F, Negri E, La Vecchia C and Lunet N:
Worldwide trends in gastric cancer mortality (1980–2011), with
predictions to 2015, and incidence by subtype. Eur J Cancer.
50:1330–1344. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chen W, Zheng R, Zhang S, Zhao P, Zeng H,
Zou X and He J: Annual report on status of cancer in China, 2010.
Chin J Cancer Res. 26:48–58. 2014.PubMed/NCBI
|
|
3
|
Zhang J, Song Y, Zhang C, Zhi X, Fu H, Ma
Y, Chen Y, Pan F, Wang K, Ni J, et al: Circulating miR-16-5p and
miR-19b-3p as two novel potential biomarkers to indicate
progression of gastric cancer. Theranostics. 5:733–745. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Di Leva G, Garofalo M and Croce CM:
MicroRNAs in cancer. Annu Rev Pathol. 9:287–314. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kohlhapp FJ, Mitra AK, Lengyel E and Peter
ME: MicroRNAs as mediators and communicators between cancer cells
and the tumor microenvironment. Oncogene. 34:5857–5868. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lan H, Lu H, Wang X and Jin H: MicroRNAs
as potential biomarkers in cancer: Opportunities and challenges.
BioMed Res Int. 2015:1250942015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ge X, Cui H, Zhou Y, Yin D, Feng Y, Xin Q,
Xu X, Liu W, Liu S and Zhang Q: miR-320a modulates cell growth and
chemosensitivity via regulating ADAM10 in gastric cancer. Mol Med
Rep. 16:9664–9670. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ji FJ, Wu YY, An Z, Liu XS, Jiang JN, Chen
FF and Fang XD: Expression of both poly r(C) binding protein 1
(PCBP1) and miRNA-3978 is suppressed in peritoneal gastric cancer
metastasis. Sci Rep. 7:154882017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yang L, Zhang W, Wang Y, Zou T, Zhang B,
Xu Y, Pang T, Hu Q, Chen M, Wang L, et al: Hypoxia-induced miR-214
expression promotes tumour cell proliferation and migration by
enhancing the Warburg effect in gastric carcinoma cells. Cancer
Lett. 414:44–56. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Sun GL, Li Z, Wang WZ, Chen Z, Zhang L, Li
Q, Wei S, Li BW, Xu JH, Chen L, et al: miR-324-3p promotes gastric
cancer development by activating Smad4-mediated Wnt/beta-catenin
signaling pathway. J Gastroenterol. Nov 4–2017.(Epub ahead of
print). doi: 10.1007/s00535-017-1408-0.
|
|
11
|
Bi L, Yang Q, Yuan J, Miao Q, Duan L, Li F
and Wang S: MicroRNA-127-3p acts as a tumor suppressor in
epithelial ovarian cancer by regulating the BAG5 gene. Oncol Rep.
36:2563–2570. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yu Y, Liu L, Ma R, Gong H, Xu P and Wang
C: MicroRNA-127 is aberrantly downregulated and acted as a
functional tumor suppressor in human pancreatic cancer. Tumour
Biol. 37:14249–14257. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhang J, Hou W, Chai M, Zhao H, Jia J, Sun
X, Zhao B and Wang R: MicroRNA-127-3p inhibits proliferation and
invasion by targeting SETD8 in human osteosarcoma cells. Biochem
Biophys Res Commun. 469:1006–1011. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Jiang H, Hua D, Zhang J, Lan Q, Huang Q,
Yoon JG, Han X, Li L, Foltz G, Zheng S, et al: MicroRNA-127-3p
promotes glioblastoma cell migration and invasion by targeting the
tumor-suppressor gene SEPT7. Oncol Rep. 31:2261–2269. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Doerks T, Copley RR, Schultz J, Ponting CP
and Bork P: Systematic identification of novel protein domain
families associated with nuclear functions. Genome Res. 12:47–56.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Cleary AS, Leonard TL, Gestl SA and
Gunther EJ: Tumour cell heterogeneity maintained by cooperating
subclones in Wnt-driven mammary cancers. Nature. 508:113–117. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Tian J, He H and Lei G: Wnt/β-catenin
pathway in bone cancers. Tumour Biol. 35:9439–9445. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Bikkavilli RK, Avasarala S, Van Scoyk M,
Arcaroli J, Brzezinski C, Zhang W, Edwards MG, Rathinam MK, Zhou T,
Tauler J, et al: Wnt7a is a novel inducer of β-catenin-independent
tumor-suppressive cellular senescence in lung cancer. Oncogene.
34:54062015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hirata T, Zheng Q, Chen Z, Kinoshita H,
Okamoto J, Kratz J, Li H, Lui N, Do H, Cheng T, et al: Wnt7A is a
putative prognostic and chemosensitivity marker in human malignant
pleural mesothelioma. Oncol Rep. 33:2052–2060. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kirikoshi H and Katoh M: Expression of
WNT7A in human normal tissues and cancer, and regulation of WNT7A
and WNT7B in human cancer. Int J Oncol. 21:895–900. 2002.PubMed/NCBI
|
|
21
|
MacLean JA II, King ML, Okuda H and
Hayashi K: WNT7A Regulation by miR-15b in ovarian cancer. PLoS One.
11:e01561092016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ramos-Solano M, Meza-Canales ID,
Torres-Reyes LA, Alvarez-Zavala M, Alvarado-Ruíz L, Rincon-Orozco
B, Garcia-Chagollan M, Ochoa-Hernández AB, Ortiz-Lazareno PC, Rösl
F, et al: Expression of WNT genes in cervical cancer-derived cells:
Implication of WNT7A in cell proliferation and migration. Exp Cell
Res. 335:39–50. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lu M, Ju S, Shen X, Wang X, Jing R, Yang
C, Chu H and Cong H: Combined detection of plasma miR-127-3p and
HE4 improves the diagnostic efficacy of breast cancer. Cancer
Biomark. 18:143–148. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Shi L, Wang Y, Lu Z, Zhang H, Zhuang N,
Wang B, Song Z, Chen G, Huang C, Xu D, et al: miR-127 promotes EMT
and stem-like traits in lung cancer through a feed-forward
regulatory loop. Oncogene. 36:1631–1643. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Gao X, Wang X, Cai K, Wang W, Ju Q, Yang
X, Wang H and Wu H: MicroRNA-127 is a tumor suppressor in human
esophageal squamous cell carcinoma through the regulation of
oncogene FMNL3. Eur J Pharmacol. 791:603–610. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Tsai KW, Wu CW, Hu LY, Li SC, Liao YL, Lai
CH, Kao HW, Fang WL, Huang KH, Chan WC, et al: Epigenetic
regulation of miR-34b and miR-129 expression in gastric cancer. Int
J Cancer. 129:2600–2610. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Guo LH, Li H, Wang F, Yu J and He JS: The
tumor suppressor roles of miR-433 and miR-127 in gastric cancer.
Int J Mol Sci. 14:14171–14184. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Polakis P: Wnt signaling in cancer. Cold
Spring Harb Perspect Biol. 4:42012. View Article : Google Scholar
|
|
30
|
Katoh Y and Katoh M: Identification and
characterization of rat Wnt6 and Wnt10a genes in silico. Int
J Mol Med. 15:527–531. 2005.PubMed/NCBI
|
|
31
|
Kim BK, Kim I and Yoon SK: Identification
of miR-199a-5p target genes in the skin keratinocyte and their
expression in cutaneous squamous cell carcinoma. J Dermatol Sci.
79:137–147. 2015. View Article : Google Scholar : PubMed/NCBI
|
